Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic *** > Treatment > USA. A. Ibrutinib *** > (*) USA Approval Date: 2016. 03.04>

First Line Treat.


(*) USA Approval Date: 2016. 03.04>'s products
This section has no products